173 related articles for article (PubMed ID: 25212061)
1. Global fee prohibits postpartum provision of the most effective reversible contraceptives.
Aiken AR; Creinin MD; Kaunitz AM; Nelson AL; Trussell J
Contraception; 2014 Nov; 90(5):466-7. PubMed ID: 25212061
[No Abstract] [Full Text] [Related]
2. Advocating for immediate postpartum LARC: increasing access, improving outcomes, and decreasing cost.
Rodriguez MI; Evans M; Espey E
Contraception; 2014 Nov; 90(5):468-71. PubMed ID: 25107639
[No Abstract] [Full Text] [Related]
3. Decreasing Unintended Pregnancy with LARC.
Hitt WC
J Ark Med Soc; 2016 Feb; 112(10):180-1. PubMed ID: 26939469
[No Abstract] [Full Text] [Related]
4. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
Secura GM; Allsworth JE; Madden T; Mullersman JL; Peipert JF
Am J Obstet Gynecol; 2010 Aug; 203(2):115.e1-7. PubMed ID: 20541171
[TBL] [Abstract][Full Text] [Related]
5. Applying principles from behavioral economics to promote long-acting reversible contraceptive (LARC) methods.
Stevens J; Berlan ED
Perspect Sex Reprod Health; 2014 Sep; 46(3):165-70. PubMed ID: 24588986
[No Abstract] [Full Text] [Related]
6. Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness.
French RS; Cowan FM; Mansour DJ; Morris S; Procter T; Hughes D; Robinson A; Guillebaud J
Health Technol Assess; 2000; 4(7):i-vi, 1-107. PubMed ID: 10944741
[No Abstract] [Full Text] [Related]
7. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant.
Espey E; Ogburn T
Obstet Gynecol; 2011 Mar; 117(3):705-719. PubMed ID: 21343774
[TBL] [Abstract][Full Text] [Related]
8. Long-Acting Reversible Contraceptives and Adolescents: Assessing Benefits and Overcoming Barriers.
McKnight ER; Berlan ED
Adolesc Med State Art Rev; 2014 Aug; 25(2):347-59. PubMed ID: 27132318
[No Abstract] [Full Text] [Related]
9. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
[TBL] [Abstract][Full Text] [Related]
10. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group
Obstet Gynecol; 2017 Nov; 130(5):e251-e269. PubMed ID: 29064972
[TBL] [Abstract][Full Text] [Related]
11. Impact of the federal contraceptive coverage guarantee on out-of-pocket payments for contraceptives: 2014 update.
Sonfield A; Tapales A; Jones RK; Finer LB
Contraception; 2015 Jan; 91(1):44-8. PubMed ID: 25288034
[TBL] [Abstract][Full Text] [Related]
12. Contraceptive procedures.
Beasley A; Schutt-Ainé A
Obstet Gynecol Clin North Am; 2013 Dec; 40(4):697-729. PubMed ID: 24286997
[TBL] [Abstract][Full Text] [Related]
13. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women.
Ricketts S; Klingler G; Schwalberg R
Perspect Sex Reprod Health; 2014 Sep; 46(3):125-32. PubMed ID: 24961366
[TBL] [Abstract][Full Text] [Related]
14. Increasing LARC utilization: any woman, any place, any time.
Hathaway M; Torres L; Vollett-Krech J; Wohltjen H
Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
[TBL] [Abstract][Full Text] [Related]
15. Regulatory Science to Promote Access to Intrauterine Systems for Women in the United States.
Sharan S; Wang Y; Donnelly M; Zou Y; Fang L; Kim MJ; Zhao L
J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S34-S38. PubMed ID: 33274507
[No Abstract] [Full Text] [Related]
16. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
17. Helping patients select long-acting reversible contraceptives.
Sierra T
JAAPA; 2019 Apr; 32(4):23-27. PubMed ID: 30913144
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
Mavranezouli I;
Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
[TBL] [Abstract][Full Text] [Related]
19. Pills are not enough: the case for long-acting reversible contraceptives--and how North Carolinians can benefit.
Bryant A; Kovar CL; Luchowski AT
N C Med J; 2009; 70(5):459-62. PubMed ID: 19999530
[No Abstract] [Full Text] [Related]
20. Committee Opinion No. 670 Summary: Immediate Postpartum Long-Acting Reversible Contraception.
Obstet Gynecol; 2016 Aug; 128(2):422-423. PubMed ID: 27454730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
